Josef Friedrich

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Merz Pharma Gmbh & Co Kgaa. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josef Friedrich. Retrieved from https://idiyas.com/inventor/josef-friedrich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Köln, DE (2017)
Rauenberg, DE (2014 - 2018)

Company Filing History:

4 out of 107

Merz Pharma Gmbh & Co Kgaa

patents

Years Active: 2014-2018

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9963502 - Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides (2018-05-08),

2. 9822223 - Method of preparing a composition based on hyaluronic acid (2017-11-21),

3. 9447175 - Means and methods for manufacturing highly pure neurotoxin (2016-09-20),

4. 8663942 - Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities (2014-03-04),

Title: Innovations of Josef Friedrich

Introduction

Josef Friedrich is a notable inventor based in Rauenberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and compositions involving neurotoxin polypeptides. With a total of four patents to his name, his work has implications for both medical and scientific advancements.

Latest Patents

Friedrich's latest patents include an innovative antibody that specifically binds to partially processed or unprocessed neurotoxin polypeptides. This invention details a method for manufacturing such antibodies and describes a composition that comprises processed neurotoxin polypeptides, free of unprocessed or partially processed variants. Additionally, he has developed a method for preparing a composition based on hyaluronic acid, which includes a crosslinked first polymer and potentially a second polymer, along with water.

Career Highlights

Josef Friedrich is currently associated with Merz Pharma GmbH & Co. KGaA, where he continues to push the boundaries of research and development in his field. His work has been instrumental in advancing therapeutic options and enhancing the understanding of neurotoxin interactions.

Collaborations

Friedrich has collaborated with notable colleagues such as Michael Pfeil and Harold Victor Taylor. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Josef Friedrich's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical science and therapeutic applications.

Profile summary based on public USPTO records.